PRediction Of Flares In Lupus with autoantibodiEs and chemokines (PROFILE)

PRediction Of Flares In Lupus with autoantibodiEs and chemokines (PROFILE) - PROFILE

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON51008

Enrollment

100

Registered

2021-07-16

Start date

2021-09-30

Completion date

Unknown

Last updated

2024-11-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lupus SLE

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: In order to be eligible to participate in this study, a subject must meet all of the following criteria: • Have a diagnosis of SLE according to EULAR/ACR criteria • Age >= 18 years

Exclusion criteria

Exclusion criteria: • Subjects participating in another study in which the subject receives immunosuppressant medication

Design outcomes

Primary

Measure	Time frame
- Profile of autoantibodies and chemokines in visits previous to recorded flares, compared to visits previous to no recorded flares. - Changes in the profile of autoantibodies and chemokines in patients with lower reported quality of life measured by LupusQoL questionnaire, compared to previous visits of the same patient.	—

Secondary

Measure	Time frame
Changes in titer levels of autoantibodies before and after start of biological treatment.	—

Countries

Netherlands

Outcome results